SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) Due to Potential for Cross Contamination with a Non-Antibacterial ßlactam Drug Substance
ß-lactam drug substance in the ibrexafungerp citrate used to manufacture the BREXAFEMME® tab